IMRX Immuneering Corporation
Healthcare$5.39+3.26%ClosedMarket Cap: $195.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$12.00
Target (Median)
$12.00
Target Range
$12.00 - $12.00
Upside from current price: 122.6%
Rating Distribution
2 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-09 | Needham | maintain | Buy | Buy |
| 2025-11-13 | Chardan Capital | maintain | Buy | Buy |
| 2025-09-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-26 | Chardan Capital | maintain | Buy | Buy |
| 2025-09-25 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-09-15 | Needham | maintain | Buy | Buy |
| 2025-08-14 | Chardan Capital | maintain | Buy | Buy |
| 2025-06-18 | Needham | maintain | Buy | Buy |
| 2025-06-18 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.34 | $16.0M | 5 |
| Sun Dec 31 | $-1.25 | $51.8M | 5 |
| Mon Dec 31 | $-0.77 | $97.5M | 1 |
| Tue Dec 31 | $0.02 | $198.5M | 1 |